Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death

Title: STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death
Authors: Janina Remy; Benedikt Linder; Ulrike Weirauch; Bryan W. Day; Brett W. Stringer; Christel Herold-Mende; Achim Aigner; Knut Krohn; Donat Kögel
Source: Cancers, Vol 14, Iss 339, p 339 (2022)
Publisher Information: MDPI AG
Publication Year: 2022
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: STAT3; glioblastoma; pimozide; autophagy; autophagy-dependent cell death; lysosome; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
Description: Glioblastoma (GBM) is a devastating disease and the most common primary brain malignancy of adults with a median survival barely exceeding one year. Recent findings suggest that the antipsychotic drug pimozide triggers an autophagy-dependent, lysosomal type of cell death in GBM cells with possible implications for GBM therapy. One oncoprotein that is often overactivated in these tumors and associated with a particularly dismal prognosis is Signal Transducer and Activator of Transcription 3 (STAT3). Here, we used isogenic human and murine GBM knockout cell lines, advanced fluorescence microscopy, transcriptomic analysis and FACS-based assessment of cell viability to show that STAT3 has an underappreciated, context-dependent role in drug-induced cell death. Specifically, we demonstrate that depletion of STAT3 significantly enhances cell survival after treatment with Pimozide, suggesting that STAT3 confers a particular vulnerability to GBM. Furthermore, we show that active STAT3 has no major influence on the early steps of the autophagy pathway, but exacerbates drug-induced lysosomal membrane permeabilization (LMP) and release of cathepsins into the cytosol. Collectively, our findings support the concept of exploiting the pro-death functions of autophagy and LMP for GBM therapy and to further determine whether STAT3 can be employed as a treatment predictor for highly apoptosis-resistant, but autophagy-proficient cancers.
Document Type: article in journal/newspaper
Language: English
Relation: https://www.mdpi.com/2072-6694/14/2/339; https://doaj.org/toc/2072-6694; https://doaj.org/article/d0fe7b9febb3444e9c9a95b0e6648345
DOI: 10.3390/cancers14020339
Availability: https://doi.org/10.3390/cancers14020339; https://doaj.org/article/d0fe7b9febb3444e9c9a95b0e6648345
Accession Number: edsbas.9EC32109
Database: BASE